Healthcare provider profile · identity verified

Jon S. Oide, MD

Internal Medicine · ELK GROVE, CA · NPI 1083792717

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	609	213
Losartan Potassium	Losartan Potassium	386	131
Amlodipine Besylate	Amlodipine Besylate	357	123
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	248	51
Levothyroxine Sodium	Levothyroxine Sodium	238	76
Famotidine	Famotidine	227	86
Lisinopril	Lisinopril	222	78
Metoprolol Succinate	Metoprolol Succinate	215	74
Fluticasone Propionate	Fluticasone Propionate	213	77
Hydrochlorothiazide	Hydrochlorothiazide	180	65
Tamsulosin Hcl	Tamsulosin Hcl	174	61
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	171	56
Metoprolol Tartrate	Metoprolol Tartrate	167	60
Furosemide	Furosemide	153	58
Albuterol Sulfate Hfa	Albuterol Sulfate	137	72
Omeprazole	Omeprazole	134	46
Pantoprazole Sodium	Pantoprazole Sodium	132	42
Simvastatin	Simvastatin	131	43
Gabapentin	Gabapentin	129	45
Metformin Hcl Er	Metformin Hcl	123	48
Alvesco	Ciclesonide	109	41
Ibuprofen	Ibuprofen	106	42
Alendronate Sodium	Alendronate Sodium	100	33
Lorazepam	Lorazepam	92	25
Allopurinol	Allopurinol	87	32
Metformin Hcl	Metformin Hcl	84	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	82	31
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	75	suppressed
Hydralazine Hcl	Hydralazine Hcl	74	23
Potassium Chloride	Potassium Chloride	73	29
Trazodone Hcl	Trazodone Hcl	69	28
Glipizide	Glipizide	68	31
Clopidogrel	Clopidogrel Bisulfate	60	20
Atenolol	Atenolol	51	20
Lovastatin	Lovastatin	50	17
Doxycycline Monohydrate	Doxycycline Monohydrate	48	41
Finasteride	Finasteride	48	20
Spiriva Respimat	Tiotropium Bromide	46	15
Fluoxetine Hcl	Fluoxetine Hcl	45	13
Tramadol Hcl	Tramadol Hcl	45	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	43	12
Sertraline Hcl	Sertraline Hcl	42	17
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	40	19
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	39	39
Cephalexin	Cephalexin	39	32
Mirtazapine	Mirtazapine	39	12
Rosuvastatin Calcium	Rosuvastatin Calcium	39	14
Montelukast Sodium	Montelukast Sodium	36	12
Terazosin Hcl	Terazosin Hcl	36	12
Triamcinolone Acetonide	Triamcinolone Acetonide	36	21
Fluocinonide	Fluocinonide	33	21
Ozempic	Semaglutide	33	suppressed
Prednisone	Prednisone	33	26
Midodrine Hcl	Midodrine Hcl	32	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	32	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	32	11
Hydrocortisone	Hydrocortisone	29	17
Pradaxa	Dabigatran Etexilate Mesylate	28	13
Warfarin Sodium	Warfarin Sodium	28	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	23
Bumetanide	Bumetanide	26	suppressed
Humulin N	Insulin Nph Human Isophane	25	15
Ondansetron Hcl	Ondansetron Hcl	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	24	suppressed
Carvedilol	Carvedilol	24	suppressed
Meloxicam	Meloxicam	22	suppressed
Jardiance	Empagliflozin	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Amoxicillin	Amoxicillin	19	18
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Breyna	Budesonide/Formoterol Fumarate	17	suppressed
Cefadroxil	Cefadroxil	17	16
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Duloxetine Hcl	Duloxetine Hcl	16	suppressed
Eliquis	Apixaban	16	suppressed
Ketoconazole	Ketoconazole	16	13
Nitroglycerin	Nitroglycerin	16	suppressed
Retin-A	Tretinoin	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	15	14
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Colchicine	Colchicine	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Humulin R	Insulin Regular, Human	13	suppressed
Naproxen	Naproxen	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Azithromycin	Azithromycin	12	11
Baclofen	Baclofen	12	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Metronidazole	Metronidazole	12	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Nystatin	Nystatin	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	11	suppressed
Zenpep	Lipase/Protease/Amylase	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error